Results 151 to 160 of about 2,397,304 (343)
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
Objective: Somatostatin receptor analogues are well-established in the treatment of metastatic gastro-enteropancreatic neuroendocrine tumours (GEP-NETs), especially for symptom control in patients with the carcinoid syndrome, and to control tumour growth.
Katharina Wang +21 more
doaj +1 more source
The causative tumor for TIO in the knee joint region is hidden and has diverse locations, resulting in great challenges to endocrinologist and orthopedists. Due to the unique anatomical location and complex structure of the knee joint, orthopedic surgeons can adopt different surgical approaches to completely remove the causative tumor.
Shuzhong Liu +7 more
wiley +1 more source
Role of Amphiphysin II in Somatostatin Receptor Trafficking in Neuroendocrine Cells [PDF]
Philippe Sarret +5 more
openalex +1 more source
Abstract figure legend The incretin system in obesity. The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) (yellow) and glucagon‐like peptide‐1 (GLP‐1) (blue) are produced by the proximal and distal small intestinal epithelium, where they are released postprandially into the bloodstream to modulate a myriad of physiological and ...
Constanza Alcaino +2 more
wiley +1 more source
Somatostatin (SS) plays an important role in regulating food intake and following digestive functions of vertebrates mediated via somatostatin receptor (SSTR).
Ran Cai +5 more
doaj +1 more source
Abstract figure legend Human intestinal organoids were genetically modified to express a fluorescent protein in enteroendocrine cells (EECs), which were then separated by flow cytometry and analysed by single‐cell RNA sequencing. High numbers of human EECs were thereby available for cluster analysis and differential gene expression, revealing ...
Christopher A. Smith +7 more
wiley +1 more source
M. Bozkurt +14 more
semanticscholar +1 more source
Figure S4 from A Somatostatin Receptor Subtype-3 (SST<sub>3</sub>) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors [PDF]
Mari C. Vázquez‐Borrego +22 more
openalex +1 more source
Abstract figure legend In our study we wanted to discover inhibitory circuits targeting layer 5 (L5) somatostatin (SST)‐expressing neurons. As putative presynaptic cells we chose parvalbumin (PV) and vasoactive intestinal polypeptide (VIP)‐expressing interneurons (IN). Previous studies showed that in L2/3 SST IN are targeted by PV and VIP cells.
Felix Preuss +4 more
wiley +1 more source

